Desvenlafaxine
- Product NDC
- 70518-3195
- 11-digit product format
- 705183195
- Labeler code
- 70518
- Product ID
- 70518-3195_c9c5850d-3a37-25f5-e053-2995a90ab350
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Desvenlafaxine
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA210014
- Marketing category
- ANDA
- Marketing start
- 2021-08-17
- Marketing end
- 0000-00-00
- Substance
- DESVENLAFAXINE SUCCINATE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 70518-3195 | D | Discontinued by firm | 2026-07-31 | ||
| excluded package | package | 70518-3195 | 70518-3195-0 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A210014-001 | DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2018-10-01 | |
| A210014-002 | DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2018-10-01 | |
| A210014-003 | DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 25MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-10-13 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A210014-001 | AB |
| A210014-002 | AB |
| A210014-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A210014-001 | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2018-10-01 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A210014-002 | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2018-10-01 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A210014-003 | DESVENLAFAXINE SUCCINATE | EQ 25MG BASE | TABLET, EXTENDED RELEASE / ORAL | AB | 2020-10-13 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A210014-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A210014-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A210014-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Desvenlafaxine | DESVENLAFAXINE | Bryant Ranch Prepack | 1d8889c9-9403-4b4b-8abd-7dc9a9fc1816 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 210014 ANDA210014 |
| Desvenlafaxine | DESVENLAFAXINE | Bryant Ranch Prepack | a6c2316d-2a51-4975-a061-dc72f2724b2f | 2026-05-14 | Boxed warning, Warnings, Adverse reactions | 210014 ANDA210014 |
| Desvenlafaxine | DESVENLAFAXINE | Bryant Ranch Prepack | 6741bdef-dc58-47be-b28d-c43476dc8bde | 2026-05-14 | Boxed warning, Warnings, Adverse reactions | 210014 ANDA210014 |
| Desvenlafaxine | DESVENLAFAXINE | Slate Run Pharmaceuticals, LLC | 44f4b928-d5b8-44e7-bfa6-81fb0dc1a718 | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 210014 ANDA210014 |
| Desvenlafaxine | DESVENLAFAXINE | A-S Medication Solutions | fd08efc0-6109-46ee-9556-f77b3f7b6baf | 2026-02-04 | Boxed warning, Warnings, Adverse reactions | 210014 ANDA210014 |
FDA-Initiated Inactive NDC Indexing#
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 70518-3195-0 | 70518319500 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-3195-0) | 2021-08-17 | 0000-00-00 | No | No | Current |